Psychedelic drugs are all over the news. Not just general news but also business media. Big news. Big Business.
PRECIOUS-Gold set for second weekly gain as dollar weakens
Gold prices gained for a fourth consecutive session on Friday, and were on track for a second straight weekly gain as a weaker U.S. dollar and growing inflationary pressure boosted demand for the safe-haven metal.
Gold price holding above $1,800 following mixed flash PMI data
The gold market is holding on to gains above $1,800 an ounce following mixed data on the health of the U.S. manufacturing and service sectors.
Costa Rica Congress Passes Medical Cannabis Legalization
Costa Rica’s Congress on Tuesday voted to legalize cannabis for medical use despite opposition from President Carlos Alvarado, Reuters reports. Independent lawmaker Zoila Volio told Reuters that she trusts Alvarado understands the reforms will not increase cannabis use in the nation and will not veto the law.
Platinum outlook: Do we need to buckle up?
The platinum group metals sector has performed very well in general over the past year on the back of a strong rebound in global car sales.
Gold Up as Dollar Inches Down, but Moves Small
Gold was up on Thursday morning in Asia, extending small gains into a third session thanks to a weakening dollar.
Small Pharma Granted Fast-Track Designation From U.K. Regulator for DMT-Assisted Therapy for Major Depressive Disorder
The UK drug regulator (MHRS) has granted Small Pharma Fast-Track Designation with respect to SPL026 for Major Depressive Disorder (MDD).
Psychedelics Industry Moving Full-Speed Ahead, When Will Stocks Catch Up?
Cash-rich psychedelic stocks are cheap. They are also building value for investors -- at an accelerating rate.
Copper price surges past $11,000 on supply squeeze
The copper price continued to rally towards record highs on Tuesday as signs of extremely tight supply outweighed concerns that slowing growth in China will impact demand.
Gold sees slight gains, silver solidly up and hits 5-wk high
Gold and silver prices are higher in midday U.S. trading Tuesday, with silver sharply up and notching a five-week high.
Numinus Advances Phase 1 Trial on Proprietary Psilocybin Product
Numinus prepares for a Phase I clinical trial of its proprietary psilocybin extract.
Small Pharma Announces Upgrade to the OTCQB® and DTC Eligibility
Small Pharma announces receiving DTC Eligibility and its OTCQB listing to broaden liquidity and increase access for U.S. investors.
